Bart K. M. Jacobs

513 total citations
25 papers, 288 citations indexed

About

Bart K. M. Jacobs is a scholar working on Infectious Diseases, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bart K. M. Jacobs has authored 25 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bart K. M. Jacobs's work include Tuberculosis Research and Epidemiology (8 papers), Pneumonia and Respiratory Infections (6 papers) and HIV/AIDS Research and Interventions (5 papers). Bart K. M. Jacobs is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Pneumonia and Respiratory Infections (6 papers) and HIV/AIDS Research and Interventions (5 papers). Bart K. M. Jacobs collaborates with scholars based in Belgium, South Africa and Switzerland. Bart K. M. Jacobs's co-authors include Limbikani Matumba, Emmanuel Njumbe Ediage, Sarah De Saeger, Christof Van Poucke, Els Goetghebeur, Lieven Clement, Lutgarde Lynen, Jo Vandesompele, Anneleen Beckers and Nina Papazova and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Clinical Infectious Diseases.

In The Last Decade

Bart K. M. Jacobs

22 papers receiving 282 citations

Peers

Countries citing papers authored by Bart K. M. Jacobs

Since Specialization

Citations

This map shows the geographic impact of Bart K. M. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart K. M. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart K. M. Jacobs more than expected).

Fields of papers citing papers by Bart K. M. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart K. M. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart K. M. Jacobs. The network helps show where Bart K. M. Jacobs may publish in the future.

Co-authorship network of co-authors of Bart K. M. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Bart K. M. Jacobs. A scholar is included among the top collaborators of Bart K. M. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart K. M. Jacobs. Bart K. M. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial 2025 ·PubMed ·(unknown), Janvier Gasana, Tom Decroo, (unknown), Bart K. M. Jacobs, Leen Rigouts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Corinne Merle, Claude Mambo Muvunyi, (unknown), Marieke G. G. Sturkenboom, Bouke C. de Jong, Jean Claude Semuto Ngabonziza	0
2	Performance of CAD4TB artificial intelligence technology in TB screening programmes among the adult population in South Africa and Lesotho 2025 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·(unknown), Keelin Murphy, Klaus Reither, (unknown), Irene Ayakaka, Tracy R. Glass, Fiona Vanobberghen, Bart K. M. Jacobs, Aita Signorell, Jabulani Ncayiyana	1
3	Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa 2024 ·Clinical Infectious Diseases ·(unknown), Irene Ayakaka, (unknown), (unknown), Alastair van Heerden, (unknown), Niklaus Daniel Labhardt, Gregor Sommer, Jens Bremerich, Thomas Zöller, Keelin Murphy, Bram van Ginneken, Alfred Keter, Bart K. M. Jacobs, Moniek Bresser, Aita Signorell, Tracy R. Glass, Lutgarde Lynen, Klaus Reither	2
4	Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis 2024 ·PLoS ONE ·Alfred Keter, Fiona Vanobberghen, Lutgarde Lynen, Alastair van Heerden, (unknown), Stephen Olivier, Emily Wong, Tracy R. Glass, Klaus Reither, Els Goetghebeur, Bart K. M. Jacobs	0
5	Development of a clinical prediction score for Ebola virus disease screening at triage centers in the Democratic Republic of the Congo 2024 ·PLOS Global Public Health ·(unknown), Antoine Tshomba, (unknown), Joule Madinga, Sabué Mulangu, Placide Mbala‐Kingebeni, Aquiles R. Henríquez-Trujillo, Bart K. M. Jacobs	0
6	Attrition one year after starting antiretroviral therapy before and after the programmatic implementation of HIV “Treat All” in Sub-Saharan Africa: a systematic review and meta-analysis 2023 ·BMC Infectious Diseases ·Richard Makurumidze, Tom Decroo, Bart K. M. Jacobs, Simbarashe Rusakaniko, Wim Van Damme, Lutgarde Lynen, (unknown)	3
7	PCR for detection of Leishmania donovani from microscopically negative tissue smears of suspected patients in Gondar, Ethiopia 2023 ·PLoS neglected tropical diseases ·(unknown), Nega Berhane, Bart K. M. Jacobs, Rezika Mohammed, (unknown), (unknown), Helina Fikre, (unknown), Saskia van Henten, Johan van Griensven, Myrthe Pareyn	2
8	MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423) 2023 ·Cancers ·Alan Jackson, (unknown), Nandita M. deSouza, (unknown), Bart K. M. Jacobs, Saskia Litière, (unknown), Catherine Julié, Arturo Chiti, Jens Theysohn, Juan Ramón Ayuso, Sigrid Stroobants, John C. Waterton	2
9	Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a community-based tuberculosis screening study 2023 ·PLoS ONE ·Alfred Keter, Lutgarde Lynen, Alastair van Heerden, Emily Wong, Klaus Reither, Els Goetghebeur, Bart K. M. Jacobs	4
10	The therapeutic threshold in clinical decision-making for TB 2023 ·International Health ·(unknown), Lutgarde Lynen, Tom Decroo, Aquiles R. Henríquez-Trujillo, Tom Boyles, Bart K. M. Jacobs	3
11	Computer-aided detection thresholds for digital chest radiography interpretation in tuberculosis diagnostic algorithms 2023 ·ERJ Open Research ·Fiona Vanobberghen, Alfred Keter, Bart K. M. Jacobs, Tracy R. Glass, Lutgarde Lynen, Irwin Law, Keelin Murphy, Bram van Ginneken, Irene Ayakaka, Alastair van Heerden, (unknown), Klaus Reither	6
12	Long-lasting insecticidal nets provide protection against malaria for only a single year in Burundi, an African highland setting with marked malaria seasonality 2022 ·BMJ Global Health ·Wim Van Bortel, Joachim Mariën, Bart K. M. Jacobs, (unknown), (unknown), (unknown), (unknown), (unknown), Anja De Weggheleire, Florian Vogt, Neil Alexander, William Wint, Peter Maes, (unknown), (unknown)	4
13	Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium 2022 ·AIDS Patient Care and STDs ·Thibaut Vanbaelen, Anke Rotsaert, Bart K. M. Jacobs, Éric Florence, Chris Kenyon, Béa Vuylsteke, Marie Laga, Thijs Reyniers	9
14	Implications of covariate induced test dependence on the diagnostic accuracy of latent class analysis in pulmonary tuberculosis 2022 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·Alfred Keter, Lutgarde Lynen, Alastair van Heerden, Els Goetghebeur, Bart K. M. Jacobs	4
15	Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study 2022 ·PLoS ONE ·(unknown), Tom Decroo, (unknown), Bart K. M. Jacobs, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Spina, (unknown), Erwan Piriou, Koert Ritmeijer, Josefien van Olmen, Htun Nyunt Oo, Lutgarde Lynen	3
16	Development of Ebola virus disease prediction scores: Screening tools for Ebola suspects at the triage-point during an outbreak 2022 ·PLoS ONE ·Antoine Tshomba, (unknown), Anja De Weggheleire, (unknown), (unknown), (unknown), Bart K. M. Jacobs, Lutgarde Lynen, Placide Mbala‐Kingebeni, Jean‐Jacques Muyembé‐Tamfum, Steve Ahuka‐Mundeke, (unknown), Désiré Tshala-Katumbay, Sabué Mulangu	4
17	Evaluation of conventional and four real-time PCR methods for the detection of Leishmania on field-collected samples in Ethiopia 2021 ·PLoS neglected tropical diseases ·Behailu Merdekios, Myrthe Pareyn, (unknown), (unknown), (unknown), Bart K. M. Jacobs, Herwig Leirs, Jean‐Pierre Van Geertruyden, Johan van Griensven, Guy Caljon, Lieselotte Cnops	24
18	Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy 2019 ·BJR\|Open ·Dominic Carlin, (unknown), Gem Kramer, Yan Liu, John C. Waterton, Arturo Chiti, Martina Sollini, Adrianus J. de Langen, Mary O'Brien, María Urbanowicz, Bart K. M. Jacobs, Nandita M. deSouza	5
19	Effectiveness of hand sorting, flotation/washing, dehulling and combinations thereof on the decontamination of mycotoxin-contaminated white maize 2015 ·Food Additives & Contaminants Part A ·Limbikani Matumba, Christof Van Poucke, Emmanuel Njumbe Ediage, Bart K. M. Jacobs, Sarah De Saeger	105
20	Impact of variance components on reliability of absolute quantification using digital PCR 2014 ·BMC Bioinformatics ·Bart K. M. Jacobs, Els Goetghebeur, Lieven Clement	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact